Detailed Study on the Effect of NeuroGen® Nerve Support Supplement on Pillar Pain after Endoscopic Carpal Tunnel Release

Abstract

Pillar pain is one of the most common complications after carpal tunnel surgery and has an occurrence from 7% - 61%. 61 patients with clinically diagnosed and electromyographically confirmed carpal tunnel syndrome were enrolled in a prospective study to evaluate the effectiveness of a nerve supplement on pillar pain after carpal tunnel surgery. All of the patients underwent endoscopic carpal tunnel release. 15 of the patients also took the nerve support supplement NeuroGen^® as part of their perioperative treatment. The supplement group demonstrated a significantly lower amount of pillar pain (VAS) at initial follow up compared to the control group (1.13 and 4.05 respectively). 46% (7/15) of the supplement group were completely free of pillar pain compared to only 9% (4/46) of the control group at the first follow up. 53% (8/15) of the NeuroGen^® group did not require any pain medications compared to 35% (16/46) of the control group. The Nerve supplement NeuroGen^® significantly reduces pain after carpal tunnel surgery. This decrease in pain results in less post-operative medication required and an earlier return to activity. Further studies will evaluate the effectiveness of the supplement on nerve regeneration after surgical decompression.